PMC:7519301 / 33016-34292
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T110 | 354-361 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T111 | 849-852 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
| T112 | 966-974 | Body_part | denotes | Appendix | http://purl.org/sig/ont/fma/fma14542 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T164 | 47-55 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T165 | 47-51 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T166 | 407-415 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T167 | 407-411 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T168 | 621-629 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T169 | 621-625 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T170 | 671-679 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T171 | 671-675 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T172 | 856-865 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
| T173 | 870-876 | Disease | denotes | Dengue | http://purl.obolibrary.org/obo/MONDO_0005502 |
| T174 | 943-951 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T175 | 943-947 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T176 | 1120-1128 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T177 | 1120-1124 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T178 | 1265-1273 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T179 | 1265-1269 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T262 | 58-61 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T263 | 78-79 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T264 | 142-145 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T265 | 153-154 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T266 | 454-459 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T267 | 471-472 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T268 | 682-689 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
| T269 | 732-733 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T270 | 780-783 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T271 | 833-840 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
| T272 | 888-895 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
| T273 | 912-913 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T274 | 954-961 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
| T275 | 1099-1100 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T95 | 354-361 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T96 | 963-965 | Chemical | denotes | SI | http://purl.obolibrary.org/obo/CHEBI_90326 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id | tao:has_standard_notation |
|---|---|---|---|---|---|---|
| 479 | 47-57 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
| 480 | 407-417 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
| 481 | 454-459 | Species | denotes | human | Tax:9606 | |
| 482 | 621-631 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
| 483 | 671-681 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
| 484 | 849-854 | Species | denotes | HIV-1 | Tax:11676 | |
| 485 | 943-953 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
| 486 | 1120-1130 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
| 487 | 1265-1275 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
| 488 | 856-865 | Species | denotes | influenza | Tax:11309 | |
| 489 | 299-304 | Mutation | denotes | D614G | p.D614G |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T200 | 0-224 | Sentence | denotes | In summary, our results indicate that, so far, SARS-CoV-2 has evolved through a nondeterministic, noisy process and that random genetic drift has played a dominant role in disseminating unique mutations throughout the world. |
| T201 | 225-406 | Sentence | denotes | Yet, it is important to note that founder effects do not exclude that the D614G can confer distinguishing properties in terms of protein stability, infectivity, or transmissibility. |
| T202 | 407-550 | Sentence | denotes | SARS-CoV-2 was only recently identified in the human population—a short time frame relative to adaptive processes that can take years to occur. |
| T203 | 551-763 | Sentence | denotes | Although we cannot predict whether adaptive selection will be seen in SARS-CoV-2 in the future, the key finding is that SARS-CoV-2 viruses that are currently circulating constitute a homogeneous viral population. |
| T204 | 764-986 | Sentence | denotes | Viral diversity has challenged vaccine development efforts for other viruses such as HIV-1, influenza, or Dengue, but these viruses each constitute a more diverse population than SARS-CoV-2 viruses (SI Appendix, Fig. S12). |
| T205 | 987-1276 | Sentence | denotes | We can therefore be cautiously optimistic that viral diversity should not be an obstacle for the development of a broadly protective SARS-CoV-2 vaccine, and that vaccines in current development should elicit responses that are reactive against currently circulating variants of SARS-CoV-2. |